DE68917830D1 - Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz. - Google Patents

Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz.

Info

Publication number
DE68917830D1
DE68917830D1 DE68917830T DE68917830T DE68917830D1 DE 68917830 D1 DE68917830 D1 DE 68917830D1 DE 68917830 T DE68917830 T DE 68917830T DE 68917830 T DE68917830 T DE 68917830T DE 68917830 D1 DE68917830 D1 DE 68917830D1
Authority
DE
Germany
Prior art keywords
substance
mammal
abdominal cavity
physiologically active
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917830T
Other languages
English (en)
Other versions
DE68917830T2 (de
Inventor
Ichiei Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIO DEFENCE INST CO Ltd
Original Assignee
BIO DEFENCE INST CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIO DEFENCE INST CO Ltd filed Critical BIO DEFENCE INST CO Ltd
Application granted granted Critical
Publication of DE68917830D1 publication Critical patent/DE68917830D1/de
Publication of DE68917830T2 publication Critical patent/DE68917830T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE68917830T 1988-08-10 1989-08-04 Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz. Expired - Fee Related DE68917830T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63199688A JPH0688906B2 (ja) 1988-08-10 1988-08-10 制癌作用を有する生物活性物質の製造方法およびそれにより得られる制癌作用を有する生物活性物質

Publications (2)

Publication Number Publication Date
DE68917830D1 true DE68917830D1 (de) 1994-10-06
DE68917830T2 DE68917830T2 (de) 1994-12-22

Family

ID=16411959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917830T Expired - Fee Related DE68917830T2 (de) 1988-08-10 1989-08-04 Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz.

Country Status (15)

Country Link
EP (1) EP0354492B1 (de)
JP (1) JPH0688906B2 (de)
KR (1) KR940003053B1 (de)
AT (1) ATE110733T1 (de)
AU (1) AU616548B2 (de)
CA (1) CA1326996C (de)
DE (1) DE68917830T2 (de)
DK (1) DK386689A (de)
ES (1) ES2059656T3 (de)
FI (1) FI100457B (de)
HK (1) HK1005190A1 (de)
HU (1) HU205257B (de)
IL (1) IL91251A (de)
NO (1) NO179327C (de)
NZ (1) NZ230250A (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
JPS58141785A (ja) * 1982-02-16 1983-08-23 Nippon Shinyaku Co Ltd 抗腫瘍物質の製法
JPS5982315A (ja) * 1982-11-02 1984-05-12 Yamanouchi Pharmaceut Co Ltd 腫瘍壊死因子の製造法
JPS6067429A (ja) * 1983-09-22 1985-04-17 Sendai Biseibutsu Kenkyusho 生理活性物質の製造法
JPS6248631A (ja) * 1985-08-26 1987-03-03 Dai Ichi Seiyaku Co Ltd 抗腫瘍血清因子
JPS6256430A (ja) * 1985-09-04 1987-03-12 Takeda Chem Ind Ltd 抗腫瘍性酸性糖蛋白

Also Published As

Publication number Publication date
NO179327B (no) 1996-06-10
KR940003053B1 (ko) 1994-04-13
AU616548B2 (en) 1991-10-31
EP0354492A3 (en) 1990-08-01
DE68917830T2 (de) 1994-12-22
CA1326996C (en) 1994-02-15
NO893194L (no) 1990-02-12
NZ230250A (en) 1992-09-25
HK1005190A1 (en) 1998-12-24
EP0354492A2 (de) 1990-02-14
FI893765A (fi) 1990-02-11
IL91251A0 (en) 1990-03-19
ES2059656T3 (es) 1994-11-16
HUT53808A (en) 1990-12-28
KR900002790A (ko) 1990-03-23
JPH0688906B2 (ja) 1994-11-09
ATE110733T1 (de) 1994-09-15
FI100457B (fi) 1997-12-15
JPH0248532A (ja) 1990-02-19
DK386689A (da) 1990-02-11
HU205257B (en) 1992-04-28
DK386689D0 (da) 1989-08-07
AU3936589A (en) 1990-02-15
EP0354492B1 (de) 1994-08-31
IL91251A (en) 1994-12-29
NO179327C (no) 1996-09-18
FI893765A0 (fi) 1989-08-09
NO893194D0 (no) 1989-08-08

Similar Documents

Publication Publication Date Title
LV11783A (lv) Savienojumi un metodes megakariocitu augsanas un diferencesanas stimulesanai
DE69433013D1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
DE3485075D1 (de) Pharmazeutische zubereitung zur heilung der erkrankungen der zahnwurzelhaut und verfahren zu deren herstellung.
ATE44156T1 (de) Kovalent gebundener heparin-antithrombin iiikomplex, verfahren zu dessen herstellung und seine verwendung zur behandlung von thrombusembolie.
DE69132472T2 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butandiol
DE68917830T2 (de) Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz.
DE4207365C2 (de) Verfahren zur in-vitro-Immunisierung von Lymphocyten sowie zum Testen auf die Immunisierung stimulierende Aktivität
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
Sumida Study of abnormal formation of the aortic arch in rats: By methacrylate casts method and by immunohistochemistry for appearance and distribution of desmin, myosin and fibronectin in the tunica media
Janczewska et al. Requirement of stromal cells in the bone marrow transplant for rapid lymphoid replenishment
EP0910624B1 (de) Verfahren zur herstellung und vermehrung von lymphozyten
ATA234789A (de) In der tierzucht verwendetes präparat sowie verfahren zu dessen herstellung
DE3990349T1 (de) Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee